Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients

BACKGROUND: Vitamin D (25-hydroxyvitamin D; 25[OH]D) deficiency (VDD) is highly prevalent in chronic kidney disease. The aim of this study was to evaluate the effect of oral ergocalciferol supplementation on requirement of erythropoietin (EPO) and active vitamin D analogues, and hospitalization rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Gaurav, Hirachan, Padam, Gelfond, Jonathan, Fanti, Paolo, Hura, Claudia, Bansal, Shweta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055677/
https://www.ncbi.nlm.nih.gov/pubmed/27717322
http://dx.doi.org/10.1186/s12882-016-0359-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055677/
https://www.ncbi.nlm.nih.gov/pubmed/27717322
http://dx.doi.org/10.1186/s12882-016-0359-7

Ejemplares similares